Cargando…

Is the tide turning against breast screening?

Herein I argue that mammographic screening has not delivered on its fundamental premise: to reduce the incidence of advanced breast cancer. Indeed, achieving this goal is required if screening is to reduce breast cancer mortality or mastectomy use. Rather, screening has caused substantial increases...

Descripción completa

Detalles Bibliográficos
Autor principal: Jørgensen, Karsten Juhl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680947/
https://www.ncbi.nlm.nih.gov/pubmed/22805502
http://dx.doi.org/10.1186/bcr3212
_version_ 1782273182912217088
author Jørgensen, Karsten Juhl
author_facet Jørgensen, Karsten Juhl
author_sort Jørgensen, Karsten Juhl
collection PubMed
description Herein I argue that mammographic screening has not delivered on its fundamental premise: to reduce the incidence of advanced breast cancer. Indeed, achieving this goal is required if screening is to reduce breast cancer mortality or mastectomy use. Rather, screening has caused substantial increases in the incidence of in situ and early invasive cancers. Moreover, evidence indicates that these screen-detected cancers are unlikely to be cases that were 'caught early', but instead represent women who would not have been diagnosed in the absence of screening and who, as a result, have received harmful, unnecessary treatment. If true, these observations raise the specter that screening creates breast cancer patients and that this practice carries little or no benefit.
format Online
Article
Text
id pubmed-3680947
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36809472013-06-25 Is the tide turning against breast screening? Jørgensen, Karsten Juhl Breast Cancer Res Editorial Herein I argue that mammographic screening has not delivered on its fundamental premise: to reduce the incidence of advanced breast cancer. Indeed, achieving this goal is required if screening is to reduce breast cancer mortality or mastectomy use. Rather, screening has caused substantial increases in the incidence of in situ and early invasive cancers. Moreover, evidence indicates that these screen-detected cancers are unlikely to be cases that were 'caught early', but instead represent women who would not have been diagnosed in the absence of screening and who, as a result, have received harmful, unnecessary treatment. If true, these observations raise the specter that screening creates breast cancer patients and that this practice carries little or no benefit. BioMed Central 2012 2012-07-13 /pmc/articles/PMC3680947/ /pubmed/22805502 http://dx.doi.org/10.1186/bcr3212 Text en Copyright ©2012 BioMed Central Ltd
spellingShingle Editorial
Jørgensen, Karsten Juhl
Is the tide turning against breast screening?
title Is the tide turning against breast screening?
title_full Is the tide turning against breast screening?
title_fullStr Is the tide turning against breast screening?
title_full_unstemmed Is the tide turning against breast screening?
title_short Is the tide turning against breast screening?
title_sort is the tide turning against breast screening?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680947/
https://www.ncbi.nlm.nih.gov/pubmed/22805502
http://dx.doi.org/10.1186/bcr3212
work_keys_str_mv AT jørgensenkarstenjuhl isthetideturningagainstbreastscreening